The oxidative modification of LDL seems a key event in atherogenesis and may participate in inflammatory tissue injury. Our previous studies suggested that the process of LDL oxidation by activated human monocytes/macrophages required O-and activity of intracellular lipoxygenase. Herein, we studied the mechanisms involved in this oxidative modification of LDL. In this study, we used the human monocytoid cell line U937 to examine the role of Ca2+ in U937 cell-mediated lipid peroxidation of LDL. U937 cells were activated by opsonized zymosan.
Activated human monocytes/macrophages can oxidize normal human LDL and transform it to a cytotoxin (1) . The process of LDL lipid peroxidation by activated human monocytes has been shown to require superoxide anion (O -) released from activated monocytes/ macrophages, since scavenging of O2 by superoxide dismutase prevents peroxidation of LDL lipids (2) . Metal ion chelators and general antioxidants can also inhibit monocyte-mediated peroxidation of LDL lipids (1, 2) . Our previous studies suggested that there was an initiation of oxidation by O2 and propagation of oxidation mediated by other free radicals, possibly lipid radicals (2) . It was also found that intracellular lipoxygenase was essential for oxidation of LDL lipids (3) . Cellular lipoxygenases catalyze the oxidation ofpolyunsaturated fatty acids to fatty acid hydroperoxides. Fatty acid hydroperoxides may propagate oxidation by forming reactive lipid peroxyl radicals.
Oxidized LDL has been shown to be toxic to proliferating target cells in vitro, such as fibroblasts and endothelial cells (1, 4, 5) . If activated monocytes/macrophages were able to oxidize LDL in vivo, the resultant toxic lipoproteins could mediate tissue injury in a variety of inflammatory responses. This may likely occur in the developing atherosclerotic lesion where lipid-laden foam cells of monocyte origin are surrounded by LDL accumulating in high concentration in the vascular interstitial space (5, 6) . Thus, it appears that phagocyte-derived free radicals, both superoxide anion and lipid peroxyl radicals, oxidize LDL and that the products oflipid peroxidation carried by oxidized LDL can effect more extensive or more distant tissue injury than that directly mediated by monocyte-derived free radicals.
Although both the release ofreactive oxygen species by activated human monocytes/macrophages and the requirement for cellular lipoxygenases have been correlated with oxidation of LDL lipids, the precise mechanisms involved in the oxidation are not entirely understood. In particular, little is known regarding the intracellular signaling required for activated monocytes to mediate oxidation of LDL. Studies on the required intracellular signaling can help elucidate the specific mechanisms of activated monocyte-mediated oxidation of LDL and conversion of LDL to cytotoxin as well as suggest optimal means for intervening and preventing this process.
For the majority of our studies opsonized zymosan (ZOP)' has been used as the activation stimulus for human monocytes. ZOP resembles a type ofstimulus that might be encountered in vivo. Since ZOP can activate the monocyte through Fc recep-tors, complement receptors, and as a stimulator of phagocytosis (7) , it is likely that several secondary messenger pathways of signal transduction are put into motion. Our hypothesis regarding activation signals and their transduction to intracellular signaling systems is that upon activation ofmonocytes/ macrophages by ZOP, several intracellular signal transduction systems are involved and that some of these may be required for cell-mediated LDL oxidation whereas others may not. Several secondary messenger-generating pathways, such as the activation of lipoxygenases, phospholipases, or protein kinases form networks ofcoregulation. In a number ofthese signal transduction pathways, Ca2+ is a critical mediator. Thus, in this study we evaluated the importance of Ca2+ influx from the extracellular environment and Ca2+ mobilization from intracellular stores in the peroxidation of LDL lipids by activated macrophages.
It has been reported that Ca2+ channel blockers may prevent atherogenesis (8) ; however, the precise mechanisms remain to be elucidated. In this paper, classic slow Ca2+ channel blockers known to block Ca2' entry through selective Ca2c hannels in the plasma membrane were used to block the entry of extracellular Ca2+ from cell culture medium. Agents known to prevent release of intracellular Ca21 from internal membrane stores were also tested. Data presented here indicate that both extracellular and intracellular Ca2+ contribute to the process ofperoxidation of LDL lipids induced by activated human macrophages. Prevention of Ca2+ entry or Ca2+ mobilization substantially interferes with the conversion of normal LDL to an oxidized and toxic entity. Our data also suggest that neither of these Ca2+ resources alone is sufficient for fully triggering monocyte-mediated LDL lipid peroxidation.
Methods
Cell culture U937 cells obtained from the American Type Culture Collection (Rockville, MD) were cultured in 150-cm2 flasks (Coming Glass Inc., Coming, NY) in RPMI 1640 (Whittaker Bioproducts, Walkersville, MD) supplemented with 10% bovine calf serum (Hyclone Laboratories Inc., Logan, UT), 100 U/ml penicillin, and 100 ag/ml streptomycin (Gibco Laboratories, Grand Island, NY) at 37°C in a humidified atmosphere of 90% air/ 10% CO2. U937 cells were maintained in log phase and were not allowed to exceed 1 X 106/ml. For experiments U937 cells were washed twice with RPMI 1640 without serum and 5 x 105 cells/ml were plated into 12-well tissue culture plates (Costar Corp., Cambridge, MA). U937 cells were cocultured with 0.5 mg LDL cholesterol/ml. Various reagents were included during the 24-h incubation ofU937 cells with LDL as noted to test for their effects on U937 cell-mediated lipid peroxidation ofLDL. The total volume per well was 1.0 ml.
Lipoprotein preparation
LDL was prepared according to previously described methods that minimize oxidation and exposure to endotoxin (9) . Each batch of LDL was assayed for endotoxin contamination by the Limulus amebocyte lysate assay. Final endotoxin contamination was < 0.015 U/ml. LDL was stored in 0.5 mM EDTA and adjusted to 10 mg cholesterol/ ml. Immediately before use, LDL was dialyzed at 4°C against phosphate-buffered saline without calcium or magnesium (Gibco Laboratories). LDL was used at a final concentration of0.5 mg cholesterol/ml.
Measurement oflipid peroxidation
The peroxidation of LDL lipids was measured by both the thiobarbituric acid (TBA) assay and lipid peroxide (LPO) assay.
TBA assay. The presence of lipid oxidation products on LDL was determined by a modification of the assay described by Schuh et LDL and ZOP were added together with 2 MCi 45Ca2+/ml. At given time intervals, 100 ,l ofcell suspension was loaded onto 500 ,l Ficoll-Paque (Pharmacia Inc., Piscataway, NJ) and centrifuged for 2 min in an Eppendorf centrifuge 5413. The cells were rapidly filtered under vacuum on GF/C glass-fiber filters (Whatman International Ltd., Maidstone, England) that were previously rinsed with 2 ml HBSS. The filters were further rinsed with 3 ml HBSS, air dried, and placed in 10 ml ofscintillation liquid (ICN Biomedicals, Inc., Irvine, CA). Radioactivity was determined with a ,B-scintillation counter. All experiments were performed in triplicate.
Detection oftoxicity oftest agents
The toxicity of test agents to U937 cells was determined by both the ['4C]adenine and the [5' Cr]sodium chromate release assays. These assays gave very similar results when U937 cells were injured with increasing doses of hydrogen peroxide in support of previously published comparisons of these sensitive assays for cell injury/toxicity ( 12).
['"C]adenine release assay (13 [51Cr]Sodium chromate release assay (14) . 1 X I0' U937 cells in 20 ml RPMI 1640 were labeled overnight by incubating with 100,MCi of sodium chromate-51 (Du Point/New England Nuclear, Boston, MA). After labeling, the cells were washed twice with RPMI 1640, and 5 X I05 cells/ml, ZOP, and LDL were plated into 12-well tissue culture plates in the presence or absence oftest agents. After 24 h, 100 l ofthe supernatants containing released isotope were removed and placed in glass tubes to be counted on a gamma counter. Controls consisted of U937 cells incubated with ZOP (0% release) or 0.2% SDS (100% release). The data are calculated according to above equation.
Intracellular Ca2" measurement Intracellular Ca2+ was measured using the fluorescent indicator Fura 2 (15) . In U937 cells, at 1 X 107/ml of Krebs-Ringer solution with the following composition (mM): (125 NaCl, 5 KCl, 1.2 MgSO4, 6 glucose, 1 CaCl2, and 25 Hepes, pH 7.5) containing 0.2% BSA, were incubated for 20 min at 370C in 4MuM Fura 2-AM (Molecular Probes, Inc., Eugene, OR). The cells were subsequently diluted fourfold and incubated an additional 20 min to completely hydrolyze the entrapped ester. The cells were pelleted and resuspended at 1.33 X 106/ ml KrebsRinger solution containing BSA for measurements. Fura 2 measurements were conducted in an air-driven dual-wavelength spectrofluorometer using excitation wavelengths of 340 and 380 nm and emission at 500 nm. Maximal fluorescence of the Ca2+-saturated dye was measured in the presence of 0.1 % Triton X-100 and minimal fluorescence was measured in the presence of5 mM EGTA and 32 mM Tris, pH 8. (16) and used at a concentration of 2 mg/ml to activate U937 cells. TMB-8, nifedipine, verapamil, ryanodine, 4-bromo A23187, and thapsigargin were solubilized in DMSO as 100-fold stock solutions. EGTA and lanthanum chloride were solubilized in H20 as 100-fold stock solutions. Opsonized zymosan was suspended in RPMI 1640 as 20-fold stock solutions. For experiments these reagents were diluted to designated concentrations in RPMI 1640 as indicated.
Results
The TBA assay is a widely used method to detect MDA and MDA-like compounds derived from lipid oxidation products ( 10) ; and the LPO assay is used to detect the presence of lipid peroxides ( 11 ) . In our studies both ofthese methods were used to detect the lipid oxidation products on LDL mediated by activated human monocytes. U937 cells, ZOP, and LDL were incubated together for 24 h. Results of three experiments are summarized in Fig. 1 . LDL was significantly oxidized by ZOPactivated U937 cells as detected by both the TBA assay (Fig. 1  A) and the LPO assay (Fig. 1 B) . Little ifany lipid peroxidation was observed in cocultures ofLDL and unactivated U937 cells. Fig. 3 indicate that prevention ofrelease ofCa21 from intracellular stores by adding either ryanodine (Fig. 3 A) or TMB-8 ( Fig. 3 B) To examine the Ca2+ involvement in activating U937 cells to oxidize LDL, a Ca2+ ionophore was tested for its ability to induce LDL lipid peroxidation by U937 cells. In these experiments, U937 cells (5 X l0 cells/ml), LDL, and 4-bromo Fig. 5 and found that none of these drug combinations was toxic for U937 cells (data not shown). Additionally, in a pilot study, we examined whether the effect of nifedipine could be reversed by removing it after pretreating U937 cells, to determine whether it irreversibly injured the cells. We found that after removing nifedipine ( 100 ,M) U937 cells were capable of oxidizing LDL lipids to a similar degree as untreated cells; thus providing further support that an agent that inhibits calcium influx can profoundly inhibit LDL lipid peroxidation without injuring the monocytes.
Finally, we tested the antioxidant activity ofthe Ca2" channel blockers and agents preventing Ca2+ release from intracellular stores that were used in the above studies to rule out a nonspecific inhibitory effect on U937 cells. (21 ) , inhibiting proliferation and activation of T lymphocytes ( 17) , and interfering with differentiation of U937 cells (22) . Our data show that in the presence of nifedipine or verapamil the peroxidation of LDL lipids by activated monocytes is significantly decreased (Fig. 2) as is 45Ca2+ influx (Fig.  4) Fig. 4 ). These data suggest that U937 cells may contain multiregulated or multiple types of receptor-operated Ca2+ channels. Existence of multiple types of Ca>2 channels in the same tissue has been reported by Ratz and Flaim (24) , who found that two types of receptor-operated Ca" channels ex-isted in smooth muscle ofbovine coronary arteries, only one of which was sensitive to verapamil. Alternatively, nifedipine and verapamil may have differing binding sites and affinity for the same Ca2" channel (25, 26) , since their molecular structures are not the same. Furthermore, since U937 cells do not have the classic voltage-sensitive L type channel, it is likely that nifedipine and verapamil operate differently in these cells than in smooth muscle cells. Precedence for the use of nifedipine and verapamil as inhibitors of Ca2+ influx has been established in U937 cells (22) and other nonexcitable cells such as T cells (17) and neutrophils (27) . Finally, it was reported that in neutrophils (27) and skeletal muscle (28) nifedipine can also bind to intracellular plasma membrane such as sarcoplasmic reticulum (28) to prevent Ca2' release. Thus, at high concentrations nifedipine may block both Ca2+ influx from extracellular medium and release from intracellular stores in U937 cells and thus prevent Ca2+-triggered intracellular signal transductions. Besides blockade ofCa2+ influx, it has been reported that nifedipine and verapamil have other potentially antiatheroslerotic effects, since both nifedipine and verapamil inhibit intracellular cholesteryl esterification in macrophages (29) . The Ca2+ dependence of this latter observation remains to be determined.
We also examined the contribution of Ca2+ mobilization from internal stores to monocyte-mediated peroxidation of LDL lipids. Two agents reported to prevent Ca2' release from internal membrane stores, TMB-8 and ryanodine, were used. TMB-8 has been reported to prevent mobilization of Ca2+ from intracellular stores without altering Ca2+ influx into the cell (18, 30, 31) . Ryanodine is believed to bind to the Ca2+ release channel in the intracellular Ca2+ stores (32) . Our data demonstrated that both TMB-8 and ryanodine had dose-dependent inhibitory effects on LDL lipid peroxidation by activated U937 cells (Fig. 3) ; an effect that was independent of direct antioxidant effects of these agents. Furthermore, neither agent inhibited 45Ca2+ influx (Fig. 4) . These results indicate that intracellular Ca2+ mobilization is required in the process of LDL lipid peroxidation.
Additionally, our data also show that Ca2+ channel blockers and agents known to prevent release of intracellular Ca2+ can have additive effects (Fig. 5) . The inhibitory effects of these two types of reagents in combination were greater than either alone. These findings support the concept that increases in intracellular Ca2+ from intracellular and extracellular sources are not functionally equivalent. Similar observations have been made by Haverstick et al. (33) in T lymphocytes.
Our findings indicate that intracellular Ca2+ concentrations regulated by both influx from the extracellular medium and release from intracellular stores are critical elements ofthe activation of monocytes/macrophages. We also investigated whether direct stimulation of an increase in intracellular Ca2+ was sufficient to induce the peroxidation of LDL lipids observed with ZOP-activated U937 cells.
U937 cells and LDL were incubated together with the Ca2+ ionophore 4-bromo A23187 or thapsigargin. This Ca2+ ionophore did not induce LDL lipid peroxidation with 5 X I05 U937 cells/ml (Fig. 6) . Furthermore, the release of intracellular Ca2+ by thapsigargin only induced a suboptimal level of LDL lipid peroxidation (Fig. 6 ). This level ofLDL lipid peroxidation was not enhanced by incubation with both thapsigargin and 4-bromo A23187 (data not shown). Therefore, the increases in intracellular Ca" levels are critical for optimal peroxidation of LDL lipids by activated U937 cells to occur. Both influx and mobilization of Ca" are required but are not sufficient for stimulating LDL lipid peroxidation equivalent to that induced by ZOP.
The functional role ofCa2+ in the cellular response to exogenous stimulus likely involves the induction of several different intracellular signal transduction pathways. As is well recognized, monocytes and other phagocytes, if stimulated by ZOP, exhibit receptor-mediated induction of multiple intracellular signal transduction pathways (7, 34, 35) . The effect ofZOP has been suggested to induce the activation of phospholipase C (PLC), which catalyzes hydrolysis of phosphatidylinositides (34) and generates the intracellular second messengers inositol phosphates (35) and diacylglycerol. Inositol phosphates induce the mobilization of intracellular Ca" from internal stores. Thus, the increase in intracellular Ca" levels with ZOP could be mediated by inositol phosphates generated by activation of PLC. Recently, Van De Winkel et al. (36) showed that crosslinking of IgG Fcy receptor by monoclonal antibodies induced an increase in intracellular Ca> levels in U937 cells. Phospholipase A2 has been shown to be a Ca2+-dependent signaling mechanism as well (37) . In other studies, we have found that inhibition, protein kinase C, phospholipase A2, or lipoxygenase pathways by using selective inhibitors destroys the ability of ZOP-activated U937 cells to oxidize LDL (reference 3 and unpublished data).
Taken together, our results indicate that increases in intracellular Ca>2 are required for peroxidation of LDL lipids by activated monocytes. Although increased intracellular Ca>2 levels are necessary for LDL lipid peroxidation, several other intracellular signal transduction pathways are likely involved, since neither stimulation ofCa>2 influx from extracellular medium nor Ca2+ release from intracellular stores could individually or together induce LDL lipid peroxidation by monocytes equivalent to that induced by ZOP. ZOP must activate other signal transduction pathways that act in concert with increased intracellular Ca>2 to stimulate the peroxidation of LDL lipids by U937 cells.
